SURVEY OF VANCOMYCIN MONITORING GUIDELINES IN ILLINOIS HOSPITALS

被引：11

作者：

FITZSIMMONS, WE

POSTELNICK, MJ

TORTORICE, PV

机构：

[1] RUSH MED COLL,DEPT PHARMACOL,CHICAGO,IL 60612

[2] NORTHWESTERN UNIV,MED CTR,DEPT PHARM,CHICAGO,IL 60611

[3] UNIV MINNESOTA,COLL PHARM,MINNEAPOLIS,MN 55455

来源：

DRUG INTELLIGENCE & CLINICAL PHARMACY | 1988年 / 22卷 / 7-8期

关键词：

D O I：

10.1177/106002808802200719

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：598 / 600

页数：3

共 15 条

[1]

CHEUNG RPF, 1986, PHARMACOTHERAPY, V6, P153

[2]

Cooper GL, 1986, VANCOMYCIN COMPREHEN

[3] VANCOMYCIN [J].

FEKETY, R .

MEDICAL CLINICS OF NORTH AMERICA, 1982, 66 (01) :175-181

[4]

GERACI JE, 1983, MAYO CLIN PROC, V58, P88

[5]

GERACI JE, 1960, P STAFF M MAYO CLIN, V35, P316

[6] COMPARISON OF STEADY-STATE PHARMACOKINETICS OF 2 DOSAGE REGIMENS OF VANCOMYCIN IN NORMAL VOLUNTEERS [J].

HEALY, DP ;

POLK, RE ;

GARSON, ML ;

ROCK, DT ;

COMSTOCK, TJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (03) :393-397

[7] STAPHYLOCOCCAL ENDOCARDITIS - LABORATORY AND CLINICAL BASIS FOR ANTIBIOTIC-THERAPY [J].

KARCHMER, AW .

AMERICAN JOURNAL OF MEDICINE, 1985, 78 (6B) :116-127

[8]

LAKE KD, 1985, PHARMACOTHERAPY, V5, P340

[9]

MATZKE GR, 1986, APPLIED PHARMACOKINE, P399

[10]

ROTSCHAFER JC, 1985, EMERG MED CLIN N AM, V17, P49

← 1 2 →